▶ 調査レポート

世界の防腐剤市場(~2027):製品タイプ別、用途別、エンドユーザー別、地域別

• 英文タイトル:Antiseptics Market Research Report by Product Type, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の防腐剤市場(~2027):製品タイプ別、用途別、エンドユーザー別、地域別 / Antiseptics Market Research Report by Product Type, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / 360iR22DV089資料のイメージです。• レポートコード:360iR22DV089
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、255ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社発行の当調査資料では、2021年に127.3億ドルであった世界の防腐剤市場規模が2022年に143.7億ドルに達し、2027年には266.8億ドルまで年平均13.12%で成長すると予測しています。当書は、防腐剤の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別(溶液、スポンジ、綿棒、ワイプ)分析、用途別(鼻ケア、オーラルケア、術前&注射ケア、スキンケア&ハイジーンケア)分析、エンドユーザー別(外来手術センター、在宅医療施設、病院&診療所、介護施設)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況などの内容をまとめています。なお、当書には、3M Company、ABC Compounding Co., Inc.、Avrio Health L.P.、Bayer AG、Becton Dickinson and Company、Cardinal Health, Inc.、Certified Safety Mfg., Inc.、Colgate-Palmolive Company、Generic Specialties, Inc.、GlaxoSmithKline PLC、Green Products Co.、Johnson & Johnson Services, Inc.などの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界の防腐剤市場規模:製品タイプ別
- 溶液の市場規模
- スポンジの市場規模
- 綿棒の市場規模
- ワイプの市場規模

・世界の防腐剤市場規模:用途別
- 鼻ケア用防腐剤の市場規模
- オーラルケア用防腐剤の市場規模
- 術前&注射ケア用防腐剤の市場規模
- スキンケア&ハイジーンケア用防腐剤の市場規模

・世界の防腐剤市場規模:エンドユーザー別
- 外来手術センターにおける市場規模
- 在宅医療施設における市場規模
- 病院&診療所における市場規模
- 介護施設における市場規模

・世界の防腐剤市場規模:地域別
- 南北アメリカの防腐剤市場規模
アメリカの防腐剤市場規模
カナダの防腐剤市場規模
ブラジルの防腐剤市場規模
...
- アジア太平洋の防腐剤市場規模
日本の防腐剤市場規模
中国の防腐剤市場規模
インドの防腐剤市場規模
韓国の防腐剤市場規模
台湾の防腐剤市場規模
...
- ヨーロッパ/中東/アフリカの防腐剤市場規模
イギリスの防腐剤市場規模
ドイツの防腐剤市場規模
インドの防腐剤市場規模
フランスの防腐剤市場規模
ロシアの防腐剤市場規模
...
- その他地域の防腐剤市場規模

・競争状況
・企業情報

The Global Antiseptics Market size was estimated at USD 12.73 billion in 2021 and expected to reach USD 14.37 billion in 2022, and is projected to grow at a CAGR 13.12% to reach USD 26.68 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Antiseptics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Solutions, Sponges, Swabs, and Wipes.

Based on Application, the market was studied across Nasal Care, Oral Care, Pre-surgical & Injectable Care, and Skin & Hygiene Care.

Based on End-User, the market was studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Nursing Homes.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Antiseptics market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antiseptics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antiseptics Market, including 3M Company, ABC Compounding Co., Inc., Avrio Health L.P., Bayer AG, Becton Dickinson and Company, Cardinal Health, Inc., Certified Safety Mfg., Inc., Colgate-Palmolive Company, Generic Specialties, Inc., GlaxoSmithKline PLC, Green Products Co., Johnson & Johnson Services, Inc., Kimberly-Clark Corporation, Kupa, Inc., Medtronic Private Limited, PSK Pharma Pvt.Ltd, Reckitt Benckiser Group Plc, and WaterJel Technologies, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Antiseptics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antiseptics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antiseptics Market?
4. What is the competitive strategic window for opportunities in the Global Antiseptics Market?
5. What are the technology trends and regulatory frameworks in the Global Antiseptics Market?
6. What is the market share of the leading vendors in the Global Antiseptics Market?
7. What modes and strategic moves are considered suitable for entering the Global Antiseptics Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Incidences of skin and infectious diseases after surgery
5.1.1.2. Favorable government initiatives to reduce cases of healthcare-associated infections (HAIs) and surgical site infections (SSIs)
5.1.1.3. Easy availability of over-the-counter (OTC) products at hospitals and in-home settings
5.1.2. Restraints
5.1.2.1. Lack of knowledge of the minimal usage of antiseptics in developing economies
5.1.3. Opportunities
5.1.3.1. Increasing R&D activities and development of new antiseptic products
5.1.3.2. Development of skin-friendly antiseptics and new packaging solutions
5.1.4. Challenges
5.1.4.1. Adverse effects of certain toxic substances
5.2. Cumulative Impact of COVID-19

6. Antiseptics Market, by Product Type
6.1. Introduction
6.2. Solutions
6.3. Sponges
6.4. Swabs
6.5. Wipes

7. Antiseptics Market, by Application
7.1. Introduction
7.2. Nasal Care
7.3. Oral Care
7.4. Pre-surgical & Injectable Care
7.5. Skin & Hygiene Care

8. Antiseptics Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Homecare Settings
8.4. Hospitals & Clinics
8.5. Nursing Homes

9. Americas Antiseptics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Antiseptics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Antiseptics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. ABC Compounding Co., Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Avrio Health L.P.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bayer AG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Becton Dickinson and Company
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardinal Health, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Certified Safety Mfg., Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Colgate-Palmolive Company
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Generic Specialties, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GlaxoSmithKline PLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Green Products Co.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Johnson & Johnson Services, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Kimberly-Clark Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Kupa, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Medtronic Private Limited
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. PSK Pharma Pvt.Ltd
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Reckitt Benckiser Group Plc
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. WaterJel Technologies, Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing